Surface Oncology Inc
F:QSOA
Income Statement
Earnings Waterfall
Surface Oncology Inc
Income Statement
Surface Oncology Inc
| Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||
| Revenue |
12
N/A
|
13
+6%
|
57
+343%
|
53
-7%
|
52
-1%
|
59
+14%
|
28
-52%
|
26
-8%
|
25
-5%
|
15
-38%
|
40
+157%
|
39
0%
|
39
-1%
|
126
+223%
|
89
-29%
|
90
+1%
|
90
+0%
|
3
-97%
|
31
+1 056%
|
31
-2%
|
30
-1%
|
30
-1%
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||
| Operating Expenses |
(48)
|
(59)
|
(63)
|
(69)
|
(72)
|
(69)
|
(74)
|
(73)
|
(71)
|
(73)
|
(69)
|
(65)
|
(62)
|
(65)
|
(67)
|
(71)
|
(75)
|
(79)
|
(86)
|
(91)
|
(94)
|
(92)
|
(88)
|
(86)
|
|
| Selling, General & Administrative |
(9)
|
(11)
|
(13)
|
(15)
|
(14)
|
(16)
|
(19)
|
(21)
|
(23)
|
(24)
|
(23)
|
(23)
|
(22)
|
(26)
|
(26)
|
(27)
|
(27)
|
(28)
|
(26)
|
(26)
|
(26)
|
(28)
|
(24)
|
(26)
|
|
| Research & Development |
(39)
|
(48)
|
(50)
|
(55)
|
(58)
|
(53)
|
(55)
|
(52)
|
(49)
|
(49)
|
(46)
|
(43)
|
(39)
|
(39)
|
(39)
|
(42)
|
(47)
|
(51)
|
(60)
|
(65)
|
(68)
|
(64)
|
(64)
|
(60)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(36)
N/A
|
(46)
-27%
|
(6)
+86%
|
(16)
-157%
|
(20)
-23%
|
(9)
+54%
|
(45)
-391%
|
(47)
-4%
|
(47)
+1%
|
(57)
-23%
|
(30)
+48%
|
(26)
+13%
|
(23)
+12%
|
62
N/A
|
22
-64%
|
18
-17%
|
15
-20%
|
(76)
N/A
|
(55)
+28%
|
(61)
-11%
|
(64)
-6%
|
(62)
+3%
|
(88)
-43%
|
(86)
+3%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||
| Interest Income Expense |
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
3
|
2
|
1
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(6)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
|
| Pre-Tax Income |
(36)
N/A
|
(45)
-27%
|
(6)
+87%
|
(15)
-164%
|
(18)
-21%
|
(7)
+64%
|
(42)
-537%
|
(44)
-5%
|
(44)
+1%
|
(55)
-26%
|
(28)
+49%
|
(25)
+11%
|
(24)
+4%
|
59
N/A
|
21
-64%
|
17
-20%
|
13
-24%
|
(78)
N/A
|
(57)
+28%
|
(63)
-11%
|
(66)
-5%
|
(64)
+4%
|
(90)
-41%
|
(93)
-3%
|
|
| Net Income | |||||||||||||||||||||||||
| Tax Provision |
(1)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(36)
|
(45)
|
(6)
|
(15)
|
(18)
|
(7)
|
(42)
|
(44)
|
(44)
|
(55)
|
(28)
|
(25)
|
(24)
|
59
|
21
|
17
|
13
|
(78)
|
(57)
|
(63)
|
(66)
|
(64)
|
(90)
|
(93)
|
|
| Net Income (Common) |
(36)
N/A
|
(45)
-25%
|
(13)
+72%
|
(15)
-17%
|
(18)
-19%
|
(7)
+63%
|
(35)
-429%
|
(44)
-26%
|
(44)
+1%
|
(55)
-26%
|
(28)
+49%
|
(25)
+11%
|
(24)
+4%
|
59
N/A
|
21
-64%
|
17
-20%
|
13
-24%
|
(78)
N/A
|
(57)
+28%
|
(63)
-11%
|
(66)
-5%
|
(64)
+4%
|
(90)
-41%
|
(93)
-3%
|
|
| EPS (Diluted) |
-1.38
N/A
|
-1.72
-25%
|
-0.71
+59%
|
-0.53
+25%
|
-0.63
-19%
|
-0.33
+48%
|
-1.25
-279%
|
-1.58
-26%
|
-1.57
+1%
|
-1.97
-25%
|
-0.9
+54%
|
-0.75
+17%
|
-0.59
+21%
|
1.56
N/A
|
0.5
-68%
|
0.39
-22%
|
0.28
-28%
|
-1.77
N/A
|
-1.13
+36%
|
-1.15
-2%
|
-1.12
+3%
|
-1.14
-2%
|
-1.47
-29%
|
-1.54
-5%
|
|